US Stock MarketDetailed Quotes

Praxis Precision Medicines (PRAX)

Watchlist
  • 342.580
  • -2.940-0.85%
Close May 15 16:00 ET
  • 342.580
  • 0.0000.00%
Post 16:10 ET
9.55BMarket Cap-25.58P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Praxis Precision Medicines (PRAX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
249.53%8.55M
1,349.13%7.46M
-35.47%302K
-54.29%357K
Operating revenue
--0
--0
--0
--0
--0
--0
249.53%8.55M
1,349.13%7.46M
-35.47%302K
-54.29%357K
Cost of revenue
Gross profit
Operating expense
41.66%105.86M
56.29%326.2M
35.88%97.04M
37.14%78.36M
101.00%76.07M
76.59%74.73M
62.02%208.72M
152.18%71.42M
119.89%57.14M
5.89%37.85M
Selling and administrative expenses
100.21%27.87M
4.93%59.08M
29.13%19.54M
-17.66%12.56M
23.39%13.06M
-9.20%13.92M
33.89%56.31M
52.33%15.13M
74.87%15.26M
4.52%10.59M
-General and administrative expense
100.21%27.87M
4.93%59.08M
29.13%19.54M
-17.66%12.56M
23.39%13.06M
-9.20%13.92M
33.89%56.31M
52.33%15.13M
74.87%15.26M
4.52%10.59M
Research and development costs
28.26%77.99M
75.26%267.12M
37.70%77.51M
57.10%65.8M
131.13%63.01M
125.34%60.81M
75.66%152.41M
206.11%56.29M
142.65%41.88M
6.43%27.26M
Operating profit
-41.66%-105.86M
-62.96%-326.2M
-51.74%-97.04M
-37.87%-78.36M
-102.91%-76.07M
-78.41%-74.73M
-58.39%-200.17M
-130.01%-63.96M
-122.74%-56.84M
-7.23%-37.49M
Net non-operating interest income expense
Other net income (expense)
144.83%13.3M
32.19%22.93M
54.12%8.13M
-10.15%4.43M
2.68%4.94M
132.83%5.43M
460.27%17.35M
468.64%5.28M
457.13%4.93M
642.44%4.81M
Other non- operating income (expenses)
144.83%13.3M
32.19%22.93M
54.12%8.13M
-10.15%4.43M
2.68%4.94M
132.83%5.43M
460.27%17.35M
468.64%5.28M
457.13%4.93M
642.44%4.81M
Income before tax
-33.57%-92.56M
-65.88%-303.27M
-51.52%-88.91M
-42.43%-73.93M
-117.67%-71.13M
-75.20%-69.3M
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
Income tax
Net income
-33.57%-92.56M
-65.88%-303.27M
-51.52%-88.91M
-42.43%-73.93M
-117.67%-71.13M
-75.20%-69.3M
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
Net income continuous Operations
-33.57%-92.56M
-65.88%-303.27M
-51.52%-88.91M
-42.43%-73.93M
-117.67%-71.13M
-75.20%-69.3M
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
Minority interest income
Net income attributable to the parent company
-33.57%-92.56M
-65.88%-303.27M
-51.52%-88.91M
-42.43%-73.93M
-117.67%-71.13M
-75.20%-69.3M
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-33.57%-92.56M
-65.88%-303.27M
-51.52%-88.91M
-42.43%-73.93M
-117.67%-71.13M
-75.20%-69.3M
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
Basic earnings per share
2.74%-3.2
-32.03%-13.48
-19.05%-3.5
-22.18%-3.36
-90.23%-3.31
-15.85%-3.29
45.37%-10.21
-50.00%-2.94
-1.10%-2.75
76.42%-1.74
Diluted earnings per share
2.74%-3.2
-32.03%-13.48
-19.05%-3.5
-22.18%-3.36
-90.23%-3.31
-15.85%-3.29
45.37%-10.21
-50.00%-2.94
-1.10%-2.75
76.42%-1.74
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 000000249.53%8.55M1,349.13%7.46M-35.47%302K-54.29%357K
Operating revenue --0--0--0--0--0--0249.53%8.55M1,349.13%7.46M-35.47%302K-54.29%357K
Cost of revenue
Gross profit
Operating expense 41.66%105.86M56.29%326.2M35.88%97.04M37.14%78.36M101.00%76.07M76.59%74.73M62.02%208.72M152.18%71.42M119.89%57.14M5.89%37.85M
Selling and administrative expenses 100.21%27.87M4.93%59.08M29.13%19.54M-17.66%12.56M23.39%13.06M-9.20%13.92M33.89%56.31M52.33%15.13M74.87%15.26M4.52%10.59M
-General and administrative expense 100.21%27.87M4.93%59.08M29.13%19.54M-17.66%12.56M23.39%13.06M-9.20%13.92M33.89%56.31M52.33%15.13M74.87%15.26M4.52%10.59M
Research and development costs 28.26%77.99M75.26%267.12M37.70%77.51M57.10%65.8M131.13%63.01M125.34%60.81M75.66%152.41M206.11%56.29M142.65%41.88M6.43%27.26M
Operating profit -41.66%-105.86M-62.96%-326.2M-51.74%-97.04M-37.87%-78.36M-102.91%-76.07M-78.41%-74.73M-58.39%-200.17M-130.01%-63.96M-122.74%-56.84M-7.23%-37.49M
Net non-operating interest income expense
Other net income (expense) 144.83%13.3M32.19%22.93M54.12%8.13M-10.15%4.43M2.68%4.94M132.83%5.43M460.27%17.35M468.64%5.28M457.13%4.93M642.44%4.81M
Other non- operating income (expenses) 144.83%13.3M32.19%22.93M54.12%8.13M-10.15%4.43M2.68%4.94M132.83%5.43M460.27%17.35M468.64%5.28M457.13%4.93M642.44%4.81M
Income before tax -33.57%-92.56M-65.88%-303.27M-51.52%-88.91M-42.43%-73.93M-117.67%-71.13M-75.20%-69.3M-48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M
Income tax
Net income -33.57%-92.56M-65.88%-303.27M-51.52%-88.91M-42.43%-73.93M-117.67%-71.13M-75.20%-69.3M-48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M
Net income continuous Operations -33.57%-92.56M-65.88%-303.27M-51.52%-88.91M-42.43%-73.93M-117.67%-71.13M-75.20%-69.3M-48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M
Minority interest income
Net income attributable to the parent company -33.57%-92.56M-65.88%-303.27M-51.52%-88.91M-42.43%-73.93M-117.67%-71.13M-75.20%-69.3M-48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -33.57%-92.56M-65.88%-303.27M-51.52%-88.91M-42.43%-73.93M-117.67%-71.13M-75.20%-69.3M-48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M
Basic earnings per share 2.74%-3.2-32.03%-13.48-19.05%-3.5-22.18%-3.36-90.23%-3.31-15.85%-3.2945.37%-10.21-50.00%-2.94-1.10%-2.7576.42%-1.74
Diluted earnings per share 2.74%-3.2-32.03%-13.48-19.05%-3.5-22.18%-3.36-90.23%-3.31-15.85%-3.2945.37%-10.21-50.00%-2.94-1.10%-2.7576.42%-1.74
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -